Case	case	O	O	O	O
report	report	O	O	O	O
:	:	O	O	O	O
acute	acute	O	O	O	O
unintentional	unintentional	O	O	O	O
carbachol	carbachol	CHEMICALS	O	OTHERS	I
intoxication	intoxication	O	O	O	O
.	.	O	O	O	O

INTRODUCTION	introduction	O	O	O	O
:	:	O	O	O	O
Intoxications	intoxications	O	O	O	O
with	with	O	O	O	O
carbachol	carbachol	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
a	a	O	O	O	O
muscarinic	muscarinic	O	O	O	O
cholinergic	cholinergic	O	O	O	O
receptor	receptor	O	O	O	O
agonist	agonist	O	O	O	O
are	are	O	O	O	O
rare	rare	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
report	report	O	O	O	O
an	an	O	O	O	O
interesting	interesting	O	O	O	O
case	case	O	O	O	O
investigating	investigating	O	O	O	O
a	a	O	O	O	O
(	(	O	O	O	O
near	near	O	O	O	O
)	)	O	O	O	O
fatal	fatal	O	O	O	O
poisoning	poisoning	O	DISEASE	OTHERS	I
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
son	son	O	O	O	O
of	of	O	O	O	O
an	an	O	O	O	O
84-year-old	84-year-old	O	O	O	O
male	male	O	O	O	O
discovered	discovered	O	O	O	O
a	a	O	O	O	O
newspaper	newspaper	O	O	O	O
report	report	O	O	O	O
stating	stating	O	O	O	O
clinical	clinical	O	O	O	O
success	success	O	O	O	O
with	with	O	O	O	O
plant	plant	CHEMICALS	O	OTHERS	I
extracts	extracts	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
Alzheimer	alzheimer	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
mode	mode	O	O	O	O
of	of	O	O	O	O
action	action	O	O	O	O
was	was	O	O	O	O
said	said	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
comparable	comparable	O	O	O	O
to	to	O	O	O	O
that	that	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
synthetic	synthetic	O	O	O	O
compound	compound	O	O	O	O
'	'	O	O	O	O
carbamylcholin	carbamylcholin	O	O	OTHERS	I
'	'	O	O	O	O
;	;	O	O	O	O
that	that	O	O	O	O
is	is	O	O	O	O
,	,	O	O	O	O
carbachol	carbachol	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

He	he	O	O	O	O
bought	bought	O	O	O	O
25	25	O	O	O	O
g	g	O	O	O	O
of	of	O	O	O	O
carbachol	carbachol	CHEMICALS	O	OTHERS	I
as	as	O	O	O	O
pure	pure	O	O	O	O
substance	substance	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
pharmacy	pharmacy	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
father	father	O	O	O	O
was	was	O	O	O	O
administered	administered	O	O	O	O
400	400	O	O	O	O
to	to	O	O	O	O
500	500	O	O	O	O
mg	mg	O	O	OTHERS	I
.	.	O	O	O	O

Carbachol	carbachol	CHEMICALS	O	OTHERS	I
concentrations	concentrations	O	O	O	O
in	in	O	O	O	O
serum	serum	O	O	O	O
and	and	O	O	O	O
urine	urine	O	O	O	O
on	on	O	O	O	O
day	day	O	O	O	O
1	1	O	O	O	O
and	and	O	O	O	O
2	2	O	O	O	O
of	of	O	O	O	O
hospital	hospital	O	O	O	O
admission	admission	O	O	O	O
were	were	O	O	O	O
analysed	analysed	O	O	O	O
by	by	O	O	O	O
HPLC-mass	hplc-mass	O	O	O	O
spectrometry	spectrometry	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
Minutes	minutes	O	O	O	O
after	after	O	O	O	O
oral	oral	O	O	O	O
administration	administration	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
developed	developed	O	O	O	O
nausea	nausea	O	DISEASE	OTHERS	I
,	,	O	O	O	O
sweating	sweating	O	O	OTHERS	I
and	and	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
finally	finally	O	O	O	O
collapsed	collapsed	O	O	O	O
.	.	O	O	O	O

Bradycardia	bradycardia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
cholinergic	cholinergic	O	O	O	O
symptoms	symptoms	O	O	O	O
and	and	O	O	O	O
asystole	asystole	O	DISEASE	OTHERS	I
occurred	occurred	O	O	O	O
.	.	O	O	O	O

Initial	initial	O	O	O	O
cardiopulmonary	cardiopulmonary	O	O	O	O
resuscitation	resuscitation	O	O	O	O
and	and	O	O	O	O
immediate	immediate	O	O	O	O
treatment	treatment	O	O	O	O
with	with	O	O	O	O
adrenaline	adrenaline	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
epinephrine	epinephrine	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
atropine	atropine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
furosemide	furosemide	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
successful	successful	O	O	O	O
.	.	O	O	O	O

On	on	O	O	O	O
hospital	hospital	O	O	O	O
admission	admission	O	O	O	O
,	,	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
intubated	intubated	O	O	O	O
,	,	O	O	O	O
bradyarrhythmic	bradyarrhythmic	O	O	O	O
patient	patient	O	O	O	O
was	was	O	O	O	O
100/65	100/65	O	O	O	O
mmHg	mmhg	O	O	O	O
.	.	O	O	O	O

Further	further	O	O	O	O
signs	signs	O	O	O	O
were	were	O	O	O	O
hyperhidrosis	hyperhidrosis	O	O	OTHERS	I
,	,	O	O	O	O
hypersalivation	hypersalivation	O	O	OTHERS	I
,	,	O	O	O	O
bronchorrhoea	bronchorrhoea	O	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
severe	severe	O	O	O	O
miosis	miosis	O	O	OTHERS	I
;	;	O	O	O	O
the	the	O	O	O	O
electrocardiographic	electrocardiographic	O	O	O	O
finding	finding	O	O	O	O
was	was	O	O	O	O
atrio-ventricular	atrio-ventricular	O	O	O	O
dissociation	dissociation	O	O	O	O
.	.	O	O	O	O

High	high	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
atropine	atropine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
up	up	O	O	O	O
to	to	O	O	O	O
50	50	O	O	O	O
mg	mg	O	O	OTHERS	I
per	per	O	O	O	O
24	24	O	O	O	O
hours	hours	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
adrenaline	adrenaline	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
dopamine	dopamine	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
necessary	necessary	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
patient	patient	O	O	O	O
was	was	O	O	O	O
extubated	extubated	O	O	O	O
1	1	O	O	O	O
week	week	O	O	O	O
later	later	O	O	O	O
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
increased	increased	O	O	O	O
dyspnoea	dyspnoea	O	O	OTHERS	I
and	and	O	O	O	O
bronchospasm	bronchospasm	O	O	OTHERS	I
necessitated	necessitated	O	O	O	O
reintubation	reintubation	O	O	O	O
.	.	O	O	O	O

Respiratory	respiratory	O	DISEASE	OTHERS	I
insufficiency	insufficiency	O	DISEASE	OTHERS	I
was	was	O	O	O	O
further	further	O	O	O	O
worsened	worsened	O	O	O	O
by	by	O	O	O	O
Proteus	proteus	O	O	OTHERS	I
mirabilis	mirabilis	O	O	OTHERS	I
infection	infection	O	DISEASE	OTHERS	I
and	and	O	O	O	O
severe	severe	O	O	O	O
bronchoconstriction	bronchoconstriction	O	O	O	O
.	.	O	O	O	O

One	one	O	O	O	O
week	week	O	O	O	O
later	later	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
was	was	O	O	O	O
again	again	O	O	O	O
extubated	extubated	O	O	O	O
and	and	O	O	O	O
3	3	O	O	O	O
days	days	O	O	O	O
later	later	O	O	O	O
was	was	O	O	O	O
transferred	transferred	O	O	O	O
to	to	O	O	O	O
a	a	O	O	O	O
peripheral	peripheral	O	O	O	O
ward	ward	O	O	O	O
.	.	O	O	O	O

On	on	O	O	O	O
the	the	O	O	O	O
next	next	O	O	O	O
day	day	O	O	O	O
he	he	O	O	O	O
died	died	O	O	O	O
,	,	O	O	O	O
probably	probably	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
result	result	O	O	O	O
of	of	O	O	O	O
heart	heart	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Serum	serum	O	O	O	O
samples	samples	O	O	O	O
from	from	O	O	O	O
the	the	O	O	O	O
first	first	O	O	O	O
and	and	O	O	O	O
second	second	O	O	O	O
days	days	O	O	O	O
contained	contained	O	O	O	O
3.6	3.6	O	O	O	O
and	and	O	O	O	O
1.9	1.9	O	O	O	O
mg/l	mg/l	O	O	O	O
carbachol	carbachol	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
respectively	respectively	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
corresponding	corresponding	O	O	O	O
urine	urine	O	O	O	O
concentrations	concentrations	O	O	O	O
amounted	amounted	O	O	O	O
to	to	O	O	O	O
374	374	O	O	O	O
and	and	O	O	O	O
554	554	O	O	O	O
mg/l	mg/l	O	O	O	O
.	.	O	O	O	O

CONCLUSION	conclusion	O	O	O	O
:	:	O	O	O	O
This	this	O	O	O	O
case	case	O	O	O	O
started	started	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
media	media	O	O	O	O
report	report	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
popular	popular	O	O	O	O
newspaper	newspaper	O	O	O	O
,	,	O	O	O	O
initiated	initiated	O	O	O	O
by	by	O	O	O	O
published	published	O	O	O	O
,	,	O	O	O	O
peer-reviewed	peer-reviewed	O	O	O	O
research	research	O	O	O	O
on	on	O	O	O	O
herbals	herbals	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
involved	involved	O	O	O	O
human	human	O	O	O	O
failure	failure	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
case	case	O	O	O	O
history	history	O	O	O	O
,	,	O	O	O	O
medical	medical	O	O	O	O
examination	examination	O	O	O	O
and	and	O	O	O	O
clinical	clinical	O	O	O	O
treatment	treatment	O	O	O	O
.	.	O	O	O	O

For	for	O	O	O	O
the	the	O	O	O	O
first	first	O	O	O	O
time	time	O	O	O	O
,	,	O	O	O	O
an	an	O	O	O	O
analytical	analytical	O	O	O	O
method	method	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
determination	determination	O	O	O	O
of	of	O	O	O	O
carbachol	carbachol	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
plasma	plasma	O	O	O	O
and	and	O	O	O	O
urine	urine	O	O	O	O
has	has	O	O	O	O
been	been	O	O	O	O
developed	developed	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
analysed	analysed	O	O	O	O
carbachol	carbachol	CHEMICALS	O	OTHERS	I
concentration	concentration	O	O	O	O
exceeded	exceeded	O	O	O	O
the	the	O	O	O	O
supposed	supposed	O	O	O	O
serum	serum	O	O	O	O
level	level	O	O	O	O
resulting	resulting	O	O	O	O
from	from	O	O	O	O
a	a	O	O	O	O
therapeutic	therapeutic	O	O	O	O
dose	dose	O	O	O	O
by	by	O	O	O	O
a	a	O	O	O	O
factor	factor	O	O	O	O
of	of	O	O	O	O
130	130	O	O	O	O
to	to	O	O	O	O
260	260	O	O	O	O
.	.	O	O	O	O

Especially	especially	O	O	O	O
in	in	O	O	O	O
old	old	O	O	O	O
patients	patients	O	O	O	O
,	,	O	O	O	O
intensivists	intensivists	O	O	O	O
should	should	O	O	O	O
consider	consider	O	O	O	O
intoxications	intoxications	O	O	O	O
(	(	O	O	O	O
with	with	O	O	O	O
cholinergics	cholinergics	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
cause	cause	O	O	O	O
of	of	O	O	O	O
acute	acute	O	O	OTHERS	I
cardiovascular	cardiovascular	O	O	OTHERS	I
failure	failure	O	O	OTHERS	I
.	.	O	O	O	O

